We are excited to announce that we have launched the generic version of THAM® (Tromethamine Injection), indicated for prevention and correction of metabolic acidosis.

This launch addresses the ongoing shortage of Tromethamine Injection in the U.S. and marks another milestone in A.forall’s U.S. expansion, being the first product commercialized under our own label.

The production of tromethamine is another big step in making high-quality medicines more affordable and accessible. Every day, we continue working on our mission: Making Affordable Medicines Available to All.

Check out the full press release here!